Related Experiment Video
Updated: Jul 11, 2025
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
Testicular cancer in 2023: Current status and recent progress
Deaglan J McHugh1,2, Jack P Gleeson3,4, Darren R Feldman1,2
1Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
CA: a Cancer Journal for Clinicians
|November 10, 2023
Summary
Testicular germ cell tumors (GCT) are common in young men, with cure rates improving significantly. However, some patients develop relapsed or refractory disease, necessitating review of current treatments and advances.
Area of Science:
- Oncology
- Urology
Background:
- Testicular germ cell tumor (GCT) is the most common solid malignancy in adolescent and young adult males.
- Significant advancements in GCT management over the past 50 years have led to improved cure rates, particularly for advanced disease.
Purpose of the Study:
- To review current evidence-based treatments for extracranial GCT.
- To discuss the acute and chronic toxicities associated with GCT treatments.
- To highlight contemporary advances and future directions in GCT management.
Main Methods:
- Literature review of evidence-based treatments for extracranial GCT.
- Analysis of data on cure rates and outcomes for advanced and refractory GCT.
- Synthesis of information on treatment-related toxicities and emerging therapies.
Main Results:
- Cure rates for advanced GCT have risen from 25% in the 1970s to nearly 80%.
- A proportion of patients (20%) experience relapsed or platinum-refractory disease, with significant mortality.
- Current treatments focus on evidence-based strategies for extracranial GCT, managing toxicities, and incorporating new advances.
Conclusions:
- While GCT outcomes have improved, challenges remain for patients with relapsed or refractory disease.
- A comprehensive understanding of current treatments, toxicities, and ongoing research is crucial for optimizing patient care.
- Continued progress in the field offers hope for further improvements in survival and quality of life for GCT patients.
Related Concept Videos
01:20Disorders of the Male Reproductive System
429
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
429
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K